Favorable results of prophylactic donor lymphocyte transfusions following allogeneic stem cell transplantation after reduced intensity conditioning for high-risk AML and MDS

被引：0
|
作者：
Schleuning, M
Schmid, C
Ledderose, G
Tischer, J
Baurmann, H
Schwerdtfeger, R
Kolb, HJ
机构：
[1] German Diagnost Clin Fdn, Ctr hematopoiet Cell Transplantat, Wiesbaden, Germany
[2] LMU, Dept Med 3, Clin Cooperat Grp Hematopoiet Transplantat, Munich, Germany
[3] GSF, Res Ctr Environm & Hlth, Munich, Germany
来源：
EXPERIMENTAL HEMATOLOGY | 2005年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
40
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [21] OUTCOME OF HIGH-RISK AND REFRACTORY AML/MDS PATIENTS AFTER FLAMSA SEQUENTIAL CHEMOTHERAPY REGIMEN FOLLOWED BY REDUCED-INTENSITY CONDITIONING AND ALLOGENEIC HEMATOPOEITIC STEM CELL TRANSPLANTATION
    Michallet, M.
    Detrait, M.
    Chevalier, P.
    Sobh, M.
    Guillaume, T.
    Thomas, X.
    Morisset, S.
    Tedone, N.
    Delaunay, J.
    Nicolini, F.
    Labussiere, H.
    Ducastelle, S.
    Fatoum, J.
    Barraco, F.
    Chelghoum, Y.
    Mohty, M.
    HAEMATOLOGICA, 2012, 97 : 265 - 266
  • [22] Allogeneic stem cell transplantation for patients with myelodysplastic syndrome and aml after MDS (SAML): Superior results with reduced intensity versus standard conditioning
    Buchholz, S.
    Dammann, E.
    Dobbelstein, C.
    Stadler, M.
    Koenecke, C.
    Weissinger, E. M.
    Hertenstein, B.
    Krauter, J.
    Eder, M.
    Ganser, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 233 - 233
  • [23] REDUCED INTENSITY CONDITIONING STEM CELL TRANSPLANTATION FOR HIGH RISK AML AND MDS - OUTCOME OF PATIENTS IN A SINGLE CENTER
    Uzunov, M.
    Wittnebel, S.
    Boccaccio, C.
    Bourhis, J. H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 134 - 134
  • [24] Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome
    Schmid, C
    Schleuning, M
    Ledderose, G
    Tischer, J
    Kolb, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5675 - 5687
  • [25] Allogeneic stem cell transplantation in AML and MDS - Reduced conditioning for increased risk? The Munich/AMLCG approach
    Schmid, C.
    Schleuning, M.
    Kolb, H. -J.
    ANNALS OF HEMATOLOGY, 2006, 85 : 101 - 104
  • [26] Reduced conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patient with high-risk MDS or sek.: AML
    Kröger, N
    Siegert, W
    Schetelig, J
    Zabelina, T
    Krueger, W
    Schrum, J
    Kabisch, H
    Zander, AR
    BONE MARROW TRANSPLANTATION, 2001, 27 : S255 - S256
  • [27] Impact of donor lymphocyte infusion on outcome after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation
    Michallet, M
    Mohty, M
    Le, QH
    Michallet, AS
    Faucher, C
    Thiebaut, A
    Tavernier, E
    Raffi, H
    Revesz, D
    Troncy, J
    Praire, A
    Gadolet, E
    Raus, N
    Dubois, V
    Gebuhrer, L
    Hequet, O
    Bourgeot, JC
    Nicolini, F
    BONE MARROW TRANSPLANTATION, 2005, 35 : S204 - S205
  • [28] The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation
    Marks, DI
    Lush, R
    Cavenagh, J
    Milligan, DW
    Schey, S
    Parker, A
    Clark, FJ
    Hunt, L
    Yin, J
    Fuller, S
    Vandenberghe, E
    Marsh, J
    Littlewood, T
    Smith, GM
    Culligan, D
    Hunter, A
    Chopra, R
    Davies, A
    Towlson, K
    Williams, CD
    BLOOD, 2002, 100 (09) : 3108 - 3114
  • [29] Reduced Intensity Conditioning in Allogeneic Stem Cell Transplantation for AML With Down Syndrome
    Muramatsu, Hideki
    Sakaguchi, Hirotoshi
    Taga, Takashi
    Tabuchi, Ken
    Adachi, Souichi
    Inoue, Masami
    Kitoh, Toshiyuki
    Suminoe, Aiko
    Yabe, Hiromasa
    Azuma, Eichi
    Shioda, Yoko
    Ogawa, Atsushi
    Kinoshita, Akitoshi
    Kigasawa, Hisato
    Osugi, Yuko
    Koike, Kazutoshi
    Kawa, Keisei
    Kato, Koji
    Atsuta, Yoshiko
    Kudo, Kazuko
    PEDIATRIC BLOOD & CANCER, 2014, 61 (05) : 925 - 927
  • [30] Busulfan Does Intensity and Outcomes in Reduced Intensity Allogeneic Stem Cell Transplantation for MDS/AML
    Chen, Yi-Bin
    Coughlin, Erin
    Cutler, Corey
    Kennedy, Kevin
    Alyea, Edwin P., III
    Armand, Philippe
    Attar, Eyal C.
    Ballen, Karen
    Dey, Bimalangshu R.
    Koreth, John
    McAfee, Steven L.
    Spitzer, Thomas R.
    Antin, Joseph H.
    Soiffer, Robert J.
    Ho, Vincent T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S114 - S115
12345